rs6628
Variant names: 
Variant summary
Our verdict is Benign. The variant received -18 ACMG points: 0P and 18B. BP4_ModerateBP6_Very_StrongBA1
The NM_000430.4(PAFAH1B1):c.*17C>T variant causes a 3 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.234 in 1,589,384 control chromosomes in the GnomAD database, including 45,961 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
 Genomes: 𝑓 0.20   (  3240   hom.,  cov: 32) 
 Exomes 𝑓:  0.24   (  42721   hom.  ) 
Consequence
 PAFAH1B1
NM_000430.4 3_prime_UTR
NM_000430.4 3_prime_UTR
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  3.27  
Publications
13 publications found 
Genes affected
 PAFAH1B1  (HGNC:8574):  (platelet activating factor acetylhydrolase 1b regulatory subunit 1) This locus was identified as encoding a gene that when mutated or lost caused the lissencephaly associated with Miller-Dieker lissencephaly syndrome. This gene encodes the non-catalytic alpha subunit of the intracellular Ib isoform of platelet-activating factor acteylhydrolase, a heterotrimeric enzyme that specifically catalyzes the removal of the acetyl group at the SN-2 position of platelet-activating factor (identified as 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine). Two other isoforms of intracellular platelet-activating factor acetylhydrolase exist: one composed of multiple subunits, the other, a single subunit. In addition, a single-subunit isoform of this enzyme is found in serum. [provided by RefSeq, Apr 2009] 
PAFAH1B1 Gene-Disease associations (from GenCC):
- lissencephaly due to LIS1 mutationInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -18 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.44). 
BP6
Variant 17-2681819-C-T is Benign according to our data. Variant chr17-2681819-C-T is described in ClinVar as Benign. ClinVar VariationId is 42175.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. 
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.253  is higher than 0.05. 
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes  0.198  AC: 30122AN: 151862Hom.:  3244  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
30122
AN: 
151862
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
GnomAD2 exomes  AF:  0.200  AC: 49213AN: 246630 AF XY:  0.202   show subpopulations 
GnomAD2 exomes 
 AF: 
AC: 
49213
AN: 
246630
 AF XY: 
Gnomad AFR exome 
 AF: 
Gnomad AMR exome 
 AF: 
Gnomad ASJ exome 
 AF: 
Gnomad EAS exome 
 AF: 
Gnomad FIN exome 
 AF: 
Gnomad NFE exome 
 AF: 
Gnomad OTH exome 
 AF: 
GnomAD4 exome  AF:  0.237  AC: 341329AN: 1437404Hom.:  42721  Cov.: 26 AF XY:  0.235  AC XY: 168435AN XY: 715806 show subpopulations 
GnomAD4 exome 
 AF: 
AC: 
341329
AN: 
1437404
Hom.: 
Cov.: 
26
 AF XY: 
AC XY: 
168435
AN XY: 
715806
show subpopulations 
African (AFR) 
 AF: 
AC: 
4143
AN: 
33100
American (AMR) 
 AF: 
AC: 
7753
AN: 
44296
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
6431
AN: 
25896
East Asian (EAS) 
 AF: 
AC: 
1570
AN: 
39602
South Asian (SAS) 
 AF: 
AC: 
13166
AN: 
85374
European-Finnish (FIN) 
 AF: 
AC: 
10405
AN: 
53272
Middle Eastern (MID) 
 AF: 
AC: 
822
AN: 
4140
European-Non Finnish (NFE) 
 AF: 
AC: 
283770
AN: 
1092220
Other (OTH) 
 AF: 
AC: 
13269
AN: 
59504
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.457 
Heterozygous variant carriers
 0 
 10445 
 20890 
 31336 
 41781 
 52226 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Exome Het
Exome Hom
Variant carriers
 0 
 9326 
 18652 
 27978 
 37304 
 46630 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
GnomAD4 genome  0.198  AC: 30123AN: 151980Hom.:  3240  Cov.: 32 AF XY:  0.193  AC XY: 14326AN XY: 74284 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
30123
AN: 
151980
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
14326
AN XY: 
74284
show subpopulations 
African (AFR) 
 AF: 
AC: 
5387
AN: 
41460
American (AMR) 
 AF: 
AC: 
2710
AN: 
15254
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
848
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
247
AN: 
5176
South Asian (SAS) 
 AF: 
AC: 
656
AN: 
4810
European-Finnish (FIN) 
 AF: 
AC: 
2093
AN: 
10536
Middle Eastern (MID) 
 AF: 
AC: 
78
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
17422
AN: 
67958
Other (OTH) 
 AF: 
AC: 
385
AN: 
2112
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.500 
Heterozygous variant carriers
 0 
 1235 
 2470 
 3706 
 4941 
 6176 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 316 
 632 
 948 
 1264 
 1580 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
332
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:6Other:1 
Revision: criteria provided, multiple submitters, no conflicts
LINK: link 
Submissions by phenotype
not specified    Benign:4 
-
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
Sep 26, 2014
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
-
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing
- -
not provided    Benign:2 
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided
- -
Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Lissencephaly due to LIS1 mutation    Other:1 
-
GeneReviews
Significance:not provided
Review Status:no classification provided
Collection Method:literature only
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.